Gapping down
In reaction to disappointing earnings/guidance/SSS: LL -19.8%, PBPB -18.8%, CATO -8.1%, HELE -6.1%, LB -5.5%, TSCO -5.4%, WDFC -5.2%, LQDT -4.6%, HELI -4.3%, FDO -2.5%, SMRT -0.5%, .
Select financial related names showing weakness: NBG -5.2%, BCS -3.6%, DB -3.5%, ING -3.2%, HSBC -2.1%, UBS -2%, LYG -1.8%.
Other news: KOS -8.7% (announced that funds affiliated with The Blackstone Group L.P. and Warburg Pincus agreed to sell an aggregate of 17 mln of Kosmos's common shares in a registered underwritten public offering), RGDO -6.3% (announces clinical hold of REGULATE-PCI trial following voluntary halt of trial by Regado), MEMP -6.3% (announces public offering of 8.6 mln common units),EROS -5% (prices 7 mln ordinary shares at a price of $14.50 by co and selling shareholders), AXLL -3.6% (announced that its PHH vinyl chloride monomer manufacturing facility in Lake Charles, Louisiana, has been repaired and the facility has returned to full operating rates; sees Q2 adjusted EBITDA of $125-130 mln), OCRX -3.4% (announces proposed public offering pursuant to an effective shelf registration), MBUU -2.9% (prices 4.8 mln shares of common stock at $18.50 per share by co and selling shareholders), WBAI -2.7% (announced that Anthony Liu will resign from his post as Chief Risk Officer), LOW -2.5% (following LL results), TKMR -2.5% (receives $1.5 mln milestone payment), ZQK -2.4% (announces additional licensing agreements), VRTX -2% (announces that Peter Mueller Executive VP of Global R&D and Chief Scientific Officer will retire), HD -1.8% (following LL results), SDRL -1.3% (refinances three high specification ultra-deepwater units), BAC -1.3% (reports indicate settlement talks have stalled).
Analyst comments: ISBC -2.1% (downgraded to Neutral from Buy at Guggenheim), QGEN -1.9% (initiated with a Market Perform at Wells Fargo), NTI -1.6% (downgraded to Neutral from Outperform at Macquarie).
In reaction to disappointing earnings/guidance/SSS: LL -19.8%, PBPB -18.8%, CATO -8.1%, HELE -6.1%, LB -5.5%, TSCO -5.4%, WDFC -5.2%, LQDT -4.6%, HELI -4.3%, FDO -2.5%, SMRT -0.5%, .
Select financial related names showing weakness: NBG -5.2%, BCS -3.6%, DB -3.5%, ING -3.2%, HSBC -2.1%, UBS -2%, LYG -1.8%.
Other news: KOS -8.7% (announced that funds affiliated with The Blackstone Group L.P. and Warburg Pincus agreed to sell an aggregate of 17 mln of Kosmos's common shares in a registered underwritten public offering), RGDO -6.3% (announces clinical hold of REGULATE-PCI trial following voluntary halt of trial by Regado), MEMP -6.3% (announces public offering of 8.6 mln common units),EROS -5% (prices 7 mln ordinary shares at a price of $14.50 by co and selling shareholders), AXLL -3.6% (announced that its PHH vinyl chloride monomer manufacturing facility in Lake Charles, Louisiana, has been repaired and the facility has returned to full operating rates; sees Q2 adjusted EBITDA of $125-130 mln), OCRX -3.4% (announces proposed public offering pursuant to an effective shelf registration), MBUU -2.9% (prices 4.8 mln shares of common stock at $18.50 per share by co and selling shareholders), WBAI -2.7% (announced that Anthony Liu will resign from his post as Chief Risk Officer), LOW -2.5% (following LL results), TKMR -2.5% (receives $1.5 mln milestone payment), ZQK -2.4% (announces additional licensing agreements), VRTX -2% (announces that Peter Mueller Executive VP of Global R&D and Chief Scientific Officer will retire), HD -1.8% (following LL results), SDRL -1.3% (refinances three high specification ultra-deepwater units), BAC -1.3% (reports indicate settlement talks have stalled).
Analyst comments: ISBC -2.1% (downgraded to Neutral from Buy at Guggenheim), QGEN -1.9% (initiated with a Market Perform at Wells Fargo), NTI -1.6% (downgraded to Neutral from Outperform at Macquarie).